Scan to Download
One power score. Smarter investment decisions
Pyxis Oncology Inc
PYXS2.250USD
-0.070-3.02%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
139.54MMarket Cap
LossP/E TTM
Pyxis Oncology Inc
2.250
-0.070-3.02%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
Total revenue
--2.82M
-100.00%0.00
--0.00
--0.00
--0.00
--16.15M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cost of revenue
----
----
--0.00
--0.00
--0.00
--475.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
12.67%22.57M
5.35%22.91M
7.53%19.11M
-6.31%23.75M
10.55%20.03M
3.80%21.75M
-53.21%17.77M
-10.70%25.35M
-29.56%18.12M
-33.24%20.95M
131.18%37.97M
144.32%28.39M
333.02%25.73M
-12.15%31.39M
258.72%16.43M
264.07%11.62M
--5.94M
--35.73M
--4.58M
--3.19M
R&D expenses
22.79%17.13M
30.82%17.04M
20.82%14.02M
20.79%17.74M
22.49%13.95M
9.48%13.03M
-61.12%11.61M
-22.84%14.69M
-33.66%11.39M
-40.71%11.90M
313.15%29.85M
142.50%19.03M
435.73%17.17M
-38.76%20.07M
130.20%7.23M
223.67%7.85M
--3.21M
--32.77M
--3.14M
--2.42M
Depreciation, depletion, and amortization
-8.55%535.00K
-50.54%552.00K
-20.29%550.00K
39.77%731.00K
11.64%585.00K
487.37%1.12M
259.38%690.00K
161.50%523.00K
229.56%524.00K
20.25%190.00K
21.52%192.00K
25.79%200.00K
-26.73%159.00K
39.82%158.00K
-21.39%158.00K
-40.89%159.00K
--217.00K
--113.00K
--201.00K
--269.00K
Operating profit
1.41%-19.75M
-308.81%-22.91M
-7.53%-19.11M
6.31%-23.75M
-10.55%-20.03M
73.25%-5.61M
53.21%-17.77M
10.70%-25.35M
29.56%-18.12M
33.24%-20.95M
-131.18%-37.97M
-144.32%-28.39M
-333.02%-25.73M
12.15%-31.39M
-258.72%-16.43M
-264.07%-11.62M
---5.94M
---35.73M
---4.58M
---3.19M
Net non-operating interest income (expenses)
Non-operating interest income
-74.42%99.00K
-67.94%84.00K
-43.14%87.00K
-14.54%194.00K
-2.27%387.00K
-75.42%262.00K
-91.83%153.00K
-68.43%227.00K
141.46%396.00K
11744.44%1.07M
26642.86%1.87M
11883.33%719.00K
2633.33%164.00K
125.00%9.00K
--7.00K
500.00%6.00K
--6.00K
--4.00K
--0.00
--1.00K
Gains from sale of securities
-45.23%896.00K
-10.17%1.16M
6.38%1.53M
11.62%1.65M
29.84%1.64M
112.19%1.29M
--1.44M
--1.48M
--1.26M
--607.00K
----
----
----
----
----
----
----
----
----
----
Return on equity
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
100.00%0.00
----
--0.00
----
---231.00K
----
--0.00
--0.00
Special income (expenses)
----
----
---20.96M
----
----
----
----
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
---410.00K
---2.56M
---2.16M
---1.10M
--0.00
--0.00
Other non-operating income (expenses)
-3.39%684.00K
-35.54%515.00K
23.96%714.00K
17.89%705.00K
25.53%708.00K
2002.63%799.00K
--576.00K
--598.00K
--564.00K
--38.00K
--0.00
--0.00
-100.00%0.00
----
--0.00
--0.00
--181.00K
----
--0.00
--0.00
Income before tax
-4.45%-18.07M
-549.82%-21.16M
-141.94%-37.73M
8.01%-21.20M
-8.80%-17.30M
83.08%-3.26M
56.80%-15.60M
16.71%-23.05M
37.79%-15.90M
38.68%-19.24M
-114.52%-36.10M
-95.23%-27.67M
-213.80%-25.56M
14.79%-31.38M
-267.53%-16.83M
-344.22%-14.18M
---8.15M
---36.83M
---4.58M
---3.19M
Income tax
--283.00K
----
---2.16M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-6.09%-18.35M
-549.82%-21.16M
-128.06%-35.57M
8.01%-21.20M
-8.80%-17.30M
83.08%-3.26M
56.80%-15.60M
16.71%-23.05M
37.79%-15.90M
38.68%-19.24M
-114.52%-36.10M
-95.23%-27.67M
-213.80%-25.56M
14.79%-31.38M
-267.53%-16.83M
-344.22%-14.18M
---8.15M
---36.83M
---4.58M
---3.19M
Net income from continuous operations
-6.09%-18.35M
-549.82%-21.16M
-128.06%-35.57M
8.01%-21.20M
-8.80%-17.30M
83.08%-3.26M
56.80%-15.60M
16.71%-23.05M
37.79%-15.90M
38.68%-19.24M
-114.52%-36.10M
-95.23%-27.67M
-213.80%-25.56M
14.79%-31.38M
-267.53%-16.83M
-344.22%-14.18M
---8.15M
---36.83M
---4.58M
---3.19M
Net income attributable to controlling interests
-6.09%-18.35M
-549.82%-21.16M
-128.06%-35.57M
8.01%-21.20M
-8.80%-17.30M
83.08%-3.26M
56.80%-15.60M
16.71%-23.05M
37.79%-15.90M
38.68%-19.24M
-114.52%-36.10M
-95.23%-27.67M
-213.80%-25.56M
14.79%-31.38M
-267.53%-16.83M
-344.22%-14.18M
---8.15M
---36.83M
---4.58M
---3.19M
Net income attributable to common shareholders
-6.09%-18.35M
-549.82%-21.16M
-128.06%-35.57M
8.01%-21.20M
-8.80%-17.30M
83.08%-3.26M
56.80%-15.60M
16.71%-23.05M
37.79%-15.90M
38.68%-19.24M
-114.52%-36.10M
-95.23%-27.67M
-213.80%-25.56M
14.79%-31.38M
-267.53%-16.83M
-344.22%-14.18M
---8.15M
---36.83M
---4.58M
---3.19M
Basic earnings per share
-3.65%-0.30
-445.95%-0.35
-65.63%-0.58
37.38%-0.35
30.96%-0.29
88.34%-0.06
66.20%-0.35
34.39%-0.56
47.42%-0.41
43.94%-0.54
-89.18%-1.04
-96.27%-0.85
-216.54%-0.79
13.68%-0.97
-292.03%-0.55
-344.22%-0.43
---0.25
---1.12
---0.14
---0.10
Diluted earnings per share
-3.65%-0.30
-445.95%-0.35
-65.63%-0.58
37.38%-0.35
30.96%-0.29
88.34%-0.06
66.20%-0.35
34.39%-0.56
47.42%-0.41
43.94%-0.54
-89.18%-1.04
-96.27%-0.85
-216.54%-0.79
13.68%-0.97
-292.03%-0.55
-344.22%-0.43
---0.25
---1.12
---0.14
---0.10
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
